Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. Among authors: hourmant m. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Free article. Clinical Trial.
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C; French Study Group for Atypical HUS. Zuber J, et al. Among authors: hourmant m. Am J Transplant. 2012 Dec;12(12):3337-54. doi: 10.1111/j.1600-6143.2012.04252.x. Epub 2012 Sep 7. Am J Transplant. 2012. PMID: 22958221 Free article.
Cognitive performance is associated with glomerular filtration rate in patients with chronic kidney disease: results from the CKD-REIN cohort.
Pépin M, Levassort H, Boucquemont J, Lambert O, Alencar de Pinho N, Turinici M, Helmer C, Metzger M, Cheddani L, Frimat L, Combe C, Fouque D, Laville M, Ayav C, Liabeuf S, Jacquelinet C, Teillet L, Stengel B, Massy ZA; CKD-REIN Study Collaborators. Pépin M, et al. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):457-466. doi: 10.1136/jnnp-2022-330347. Epub 2023 Jan 24. J Neurol Neurosurg Psychiatry. 2023. PMID: 36693722 Clinical Trial.
A new approach for cognitive impairment pattern in chronic kidney disease.
Levassort H, Boucquemont J, Alencar de Pinho N, Lambert O, Helmer C, Metzger M, Teillet L, Frimat L, Combe C, Fouque D, Laville M, Jacquelinet C, Liabeuf S, Stengel B, Massy ZA, Pépin M; CKD-REIN Study Collaborators. Levassort H, et al. Nephrol Dial Transplant. 2024 Apr 26;39(5):848-859. doi: 10.1093/ndt/gfad244. Nephrol Dial Transplant. 2024. PMID: 37950574
[Presentation of the green dialysis guide].
Hourmant M, Huré F. Hourmant M, et al. Soins. 2024 May;69(885):34-36. doi: 10.1016/j.soin.2024.03.008. Epub 2024 Apr 30. Soins. 2024. PMID: 38762231 Free article. French.
Improving Gender Equity for Women in Nephrology: A Global Perspective.
Karam S, Anandh U, Hocine A, Rheault MN, Sautenet B, Hourmant M. Karam S, et al. Among authors: hourmant m. Kidney Int Rep. 2024 Jan 24;9(3):501-503. doi: 10.1016/j.ekir.2024.01.036. eCollection 2024 Mar. Kidney Int Rep. 2024. PMID: 38481494 Free PMC article. No abstract available.
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.
El Chamieh C, Larabi IA, Alencar De Pinho N, Lambert O, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Laville S, Lange C, Alvarez JC, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. El Chamieh C, et al. Clin Kidney J. 2023 Sep 28;17(1):sfad248. doi: 10.1093/ckj/sfad248. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186868 Free PMC article.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD.
Laville SM, Gras-Champel V, Hamroun A, Moragny J, Lambert O, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Bieber B, Stengel B, Alencar De Pinho N, Massy ZA, Liabeuf S; CKD-REIN Study Group. Laville SM, et al. Am J Kidney Dis. 2024 May;83(5):601-614.e1. doi: 10.1053/j.ajkd.2023.09.012. Epub 2023 Nov 10. Am J Kidney Dis. 2024. PMID: 37951340 Free article.
238 results